Antibody-Drug Conjugate

Other Others Related Inhibitors

PROTAC Others Antineoplastic and Immunosuppressive Antibiotics Selection Antibiotics for Transfected Cell Antibiotics for Mammalian Cell Culture Antibiotics for Plant Cell Culture ADC Cytotoxin ADC Linker Drug-Linker Conjugates for ADC Hydrotropic Agents

Cat.No.	Product Name	Information	Product Use Citations	Product Validations
E0200	Trastuzumab-deruxtecan (DS-8201a, T-DXd)	Trastuzumab deruxtecan (DS-8201a, T-DXd) is an antibody-drug conjugate (ADC) composed of an anti-HER2 (human epidermal growth factor receptor 2) antibody and a cytotoxic topoisomerase I inhibitor. Trastuzumab deruxtecan shows durable antitumor activity. Trastuzumab deruxtecan has a molecular weight of 153KDa. This product is supplied as 10mg/ml PBS solution.This product is discontinued. We recommend the replacement products: D4001.	Proceedings of the National Academy of Sciences, May 6, 2024, e2322688121 JCI Insight, 2025, 10(16)e187151
E2851	Trastuzumab-Emtansine（T-DM1）	Trastuzumab Emtansine(T-DM1,Ado-Trastuzumab emtansine) is an antibody-drug conjugate (ADC) that incorporates the HER2-targeted antitumor properties of trastuzumab with the cytotoxic activity of the microtubule-inhibitory agent DM1.Trastuzumab emtansine has a molecular weight of 145kDa.This product is supplied as 10mg/ml PBS solution. This product is discontinued. We recommend the replacement products: D4003

Cat.No.

Product Name

Information

Product Use Citations

Product Validations

E0200

Trastuzumab-deruxtecan (DS-8201a, T-DXd)

Trastuzumab deruxtecan (DS-8201a, T-DXd) is an antibody-drug conjugate (ADC) composed of an anti-HER2 (human epidermal growth factor receptor 2) antibody and a cytotoxic topoisomerase I inhibitor. Trastuzumab deruxtecan shows durable antitumor activity. Trastuzumab deruxtecan has a molecular weight of 153KDa. This product is supplied as 10mg/ml PBS solution.This product is discontinued. We recommend the replacement products: D4001.

Proceedings of the National Academy of Sciences, May 6, 2024, e2322688121

JCI Insight, 2025, 10(16)e187151

E2851

Trastuzumab-Emtansine（T-DM1）

Trastuzumab Emtansine(T-DM1,Ado-Trastuzumab emtansine) is an antibody-drug conjugate (ADC) that incorporates the HER2-targeted antitumor properties of trastuzumab with the cytotoxic activity of the microtubule-inhibitory agent DM1.Trastuzumab emtansine has a molecular weight of 145kDa.This product is supplied as 10mg/ml PBS solution. This product is discontinued. We recommend the replacement products: D4003